The researchers of this study sought to quantify the difference in antipsychotic and antidepressant exposure among patients with genetically associated CYP2C19 and CYP2D6 poor (PM), intermediate (IM), and normal (NM) metabolizers.
Investigators looked into the risks of receiving disability services after a first diagnosis of mood or common mental disorder.
Implementation of complimentary, alternative, and integrative medicine can help improve patient symptoms in scenarios where conservative treatments have failed.
There have been few studies that have examined the specificity of mood disorder subtypes among the children of parents with both major subtypes of mood disorders and controls based on prospective tracking across the transition from childhood to adulthood.
The relationship of palmoplantar plaque psoriasis and comorbidities known to be associated with generalized plaque psoriasis were examined.
Women who stopped antidepressant treatment during pregnancy and resumed in the following weeks had a rebound effect of increased prescription of benzodiazepines and anxiolytics.
Children exposed to maternal depression have an increased risk for developmental vulnerability at school entry, with stronger associations for exposure to maternal depression before age 1 year and between ages 4 and 5 years.
Investigators conducted a population-based study in which a survey was deployed to assess the impact of the COVID-19 pandemic on mental health and well-being.
The approval was based on the ASPIRE I and II trials that compared the efficacy and safety of esketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, to placebo in 449 adults with moderate to severe MDD who had active suicidal ideation and intent.
Botox injections, which are commonly used to lessen wrinkles, migraines, muscle spasms, excessive sweating, and incontinence, may also help treat depression.